On Friday, Morgan Stanley reiterated its Overweight rating on Lineage Inc (NASDAQ: LINE) with a steadfast $100.00 price target. The firm's position reflects confidence in the company's robust growth prospects, underscored by management's expectation to achieve mid-single digit same-store growth by the end of 2024.
This anticipated growth is projected even without any market improvement, indicating that Lineage has several strategies in place to support its expansion.
The company's growth is not solely reliant on market conditions but also on its ability to capitalize on external opportunities. With limited competition from institutions and private equity for acquisitions, Lineage is well-positioned to pursue its development goals. Currently, there are eight assets under construction, which signals the company's commitment to expanding its operational capabilities.
Furthermore, Lineage's acquisition strategy is particularly noteworthy. The company believes it can acquire assets at a multiple of 12-14 times EBITDA, a significant reduction from the current multiple of 20 times. This strategy is expected to bring immediate accretion to the company's value, along with potential revenue and expense synergies.
The analyst's comments underline the firm's top pick status for Lineage, emphasizing the multiple avenues of upside to the company's solid growth foundation. Morgan Stanley's reiteration of the Overweight rating and price target reflects a strong vote of confidence in Lineage's strategic direction and its potential for continued financial performance.
In other recent news, Lineage Inc., a global temperature-controlled warehouse Real Estate Investment Trust, has declared a prorated quarterly cash dividend of $0.38 per share for the third quarter of 2024, reflecting an annualized dividend rate of $2.11 per share.
This financial event follows the company's recent transition to a publicly traded entity post-IPO. In addition, Lineage has been the subject of multiple analyst firms initiating coverage.
KeyBanc Capital Markets started coverage with an Overweight rating, citing lower leverage and substantial funds for future investments following a successful IPO. Scotiabank initiated coverage with a Sector Outperform rating, projecting an 11% compound annual growth rate in adjusted funds from operations from 2023 to 2026.
Truist Securities began its coverage with a Buy rating, emphasizing Lineage's strong growth profile and aggressive expansion strategy. UBS initiated coverage with a Neutral rating, suggesting that potential growth is already reflected in the current stock price.
Wells Fargo initiated coverage with an Equal Weight rating, based on the firm's analysis of Lineage's fiscal year 2025 and 2026 adjusted funds from operations estimates. These are all recent developments that investors should be aware of regarding Lineage Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.